AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray
AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the ...
Assessment method may improve the reliability of radiologists' diagnostic reports
Due to the inherent ambiguity in medical images like X-rays, radiologists often use words like "may" or "likely" when ...
Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...